Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2600 of 3173 entries
View as:

Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

Phase: N/A Priority: Normal
NCT ID: NCT00219583 Org: User:
Start: 08/31/04 End: 06/30/05 Due: 06/30/06

Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01347866 Org: User:
Start: 10/31/11 End: 12/31/15 Due: 12/31/16

A Multi-National Study To Assess How Effective And Safe The Smoking Cessation Medicine Varenicline Is In Smokers Who Have Already Tried Varenicline In The Past As A Prescription Medicine From Their Usual Healthcare Provider

Phase: N/A Priority: Normal
NCT ID: NCT01244061 Org: User:
Start: 12/31/10 End: 11/30/12 Due: 11/30/13

A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone

Phase: N/A Priority: Normal
NCT ID: NCT00265317 Org: User:
Start: 06/30/06 End: 01/31/12 Due: 01/31/13

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00471146 Org: User:
Start: 07/31/07 End: 11/30/10 Due: 11/30/11

Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600.

Phase: N/A Priority: Normal
NCT ID: NCT03929510 Org: User:
Start: 04/23/19 End: 07/05/19 Due: 07/05/20

A Study to Learn About the Study Medicine - Precedex in Children From Japan.

Phase: N/A Priority: Normal
NCT ID: NCT06085573 Org: User:
Start: 10/18/23 End: 06/20/25 Due: 06/20/26

Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00474760 Org: User:
Start: 08/31/05 End: 10/31/12 Due: 10/31/13

Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns

Phase: N/A Priority: Normal
NCT ID: NCT00728624 Org: User:
Start: 11/30/08 End: 09/30/09 Due: 09/30/10

US Inhaled Insulin Dose Titration Study

Phase: N/A Priority: Normal
NCT ID: NCT00246623 Org: User:
Start: 11/30/05 End: 03/31/07 Due: 03/31/08

Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX.

Phase: N/A Priority: Normal
NCT ID: NCT00141128 Org: User:
Start: 12/31/05 End: 06/30/06 Due: 06/30/07

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Phase: N/A Priority: Normal
NCT ID: NCT03828617 Org: User:
Start: 02/14/19 End: 10/09/19 Due: 10/09/20

A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Phase: N/A Priority: Normal
NCT ID: NCT05363072 Org: User:
Start: 05/02/22 End: 06/08/22 Due: 06/08/23

Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.

Phase: N/A Priority: Normal
NCT ID: NCT00463762 Org: User:
Start: 05/31/07 End: - Due: -

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04642079 Org: User:
Start: 12/04/20 End: 04/06/22 Due: 04/06/23

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

Phase: N/A Priority: Normal
NCT ID: NCT03034044 Org: User:
Start: 01/31/17 End: 01/17/18 Due: 01/17/19

Non-Comparative Study of Fluconazole in Patients With Serious Mycoses and Who Cannot Be Treated With Conventional Antifungal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00002038 Org: User:
Start: - End: - Due: -

Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT02156895 Org: User:
Start: 07/17/18 End: 08/06/21 Due: 08/06/22

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis

Phase: N/A Priority: Normal
NCT ID: NCT04682639 Org: User:
Start: 12/15/20 End: 06/30/23 Due: 06/30/24

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

Phase: N/A Priority: Normal
NCT ID: NCT05795062 Org: User:
Start: 03/10/23 End: 09/30/23 Due: 09/30/24

Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01230385 Org: User:
Start: 10/31/10 End: 05/31/11 Due: 05/31/12

A Study of Lorlatinib in ALK Inhibitor-Treated ALK-Positive NSCLC in China

Phase: N/A Priority: Normal
NCT ID: NCT03909971 Org: User:
Start: 04/28/19 End: 10/21/24 Due: 10/21/25

A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05900154 Org: User:
Start: 06/22/23 End: 02/29/24 Due: 02/28/25

A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine (5-HMT) In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01566760 Org: User:
Start: 05/31/12 End: 07/31/12 Due: 07/31/13

A Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00998764 Org: User:
Start: 12/31/09 End: 11/30/12 Due: 11/30/13